The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sonrotoclax (BGB-11417) + zanubrutinib (SZ) vs venetoclax + acalabrutinib (AV) in treatment-naive chronic lymphocytic leukemia (TN CLL): A phase 3 randomized trial design (CELESTIAL-TNCLL-2).
 
Mazyar Shadman
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Ascentage Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Fate therapeutics; Genentech; Genmab; Johnson & Johnson/Janssen; Kite, a Gilead company; Lilly; Merck; MorphoSys; Nurix; Pierre Fabre
Research Funding - Abbvie (Inst); AstraZeneca; BeiGene (Inst); Bristol-Myers Squibb/Celgene; Genentech (Inst); Genmab (Inst); Merck (Inst); Nurix; Sana Biotechnology
Patents, Royalties, Other Intellectual Property - Koi Biotherapeutics (Stock options); Koi Biotherapeutics Stock options
 
Jennifer Brown
Consulting or Advisory Role - AbbVie, Acerta/AstraZeneca, Alloplex Biotherapeutics, BeOne Medicines, Ltd, BMS, EcoR1, Galapagos NV, Genentech/Roche, Grifols Worldwide Operations, InnoCare Pharma, Lilly, Magnet Biomedicine, Merck, Nurix Therapeutics, Pharmacyclics
Research Funding - BeOne Medicines, Ltd, Gilead, iOnctura, Lilly, MEI Pharma, Nagoon Therapeutics
Patents, Royalties, Other Intellectual Property - UpToDate; Data Safety Monitoring Board for Grifols Therapeutics.
 
Tanya Siddiqi
Consulting or Advisory Role - AbbVie, AstraZeneca, BeOne Medicines, Ltd, BMS, Gilead, Pfizer
Research Funding - Bristol-Myers Squibb
 
Loic Ysebaert
Honoraria - AbbVie, BeOne Medicines, Ltd, AstraZeneca, BMS, Gilead/Kite Pharma, Johnson & Johnson, Roche
Consulting or Advisory Role - BMS, Roche, Gilead/Kite Pharma, AstraZeneca, Johnson & Johnson, BeOne Medicines, Ltd, AbbVie
Research Funding - BeOne Medicines, Ltd, AstraZeneca, Johnson & Johnson, Roche, AbbVie, Gilead/Kite Pharma
Travel, Accommodations, Expenses - AbbVie, AstraZeneca, BeOne Medicines, Ltd, Gilead/Kite Pharma, Johnson & Johnson
 
Paolo Ghia
Honoraria - Abbvie; AstraZeneca; BeiGene; Galapagos NV; Gilead Sciences; Janssen Oncology; Juno/Celgene/Bristol-Myers Squibb; Lilly; MSD; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene/Juno; Galapagos NV; Janssen; Lilly; MSD; Roche
Research Funding - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene/Juno (Inst); Janssen Oncology; Lilly
 
Jianyong Li
No Relationships to Disclose
 
Constantine Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Loxo/Lilly; Roche/Genentech
Consulting or Advisory Role - Abbvie; BeiGene; Janssen; Loxo; Roche
Research Funding - Abbvie (Inst); BeiGene (Inst); Janssen-Cilag (Inst)
 
Alicia Palomino Mosquera
Employment - BeOne Medicines; Daiichi Sankyo
Stock and Other Ownership Interests - BeOne Medicines
 
Wai Chan
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines; Bristol-Myers Squibb
 
Zaixing Shi
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines
 
Arnon Kater
Consulting or Advisory Role - AbbVie, BMS, Janssen, AstraZeneca, BeOne Medicines, Ltd, Genmab
Research Funding - AbbVie, BMS, Janssen, AstraZeneca, BeOne Medicines, Ltd, Genmab
Patents, Royalties, Other Intellectual Property - Janssen